Allergen immunotherapy in atopic dermatitis: Light and shadow in children

被引：14

作者：

Caminiti, Lucia ^{[1
]}

Panasiti, Ilenia ^{[1
]}

Landi, Massimo ^{[2
]}

De Filippo, Maria ^{[3
]}

Olcese, Roberta ^{[4
]}

Ciprandi, Giorgio ^{[5
]}

Vernich, Mario ^{[6
]}

Carelli, Francesco ^{[7
]}

Votto, Martina ^{[3
]}

Barberi, Salvatore ^{[6
]}

机构：

[1] Univ Messina, Allergy Unit, Dept Paediat, Messina, Italy

[2] Inst Biomed Res & Innovat IRIB, Paediat Natl Healthcare Syst Turin, Turin, Italy

[3] Univ Pavia, Fdn IRCSS Policlin San Matteo, Paediat Clin, Dept Paediat, Pavia, Italy

[4] Ist Giannina Gaslini, Allergy Ctr, Genoa, Italy

[5] Casa Cura Villa Montallegro, Allergy Clin, Genoa, Italy

[6] RHO, ASST Rhodense, Paediat Unit, Milan, Italy

[7] Policlin Giovanni XXIII, Azienza Osped Univ, Paediat Unit, Bari, Italy

来源：

PEDIATRIC ALLERGY AND IMMUNOLOGY | 2020年 / 31卷

关键词：

allergic immunotherapy; Atopic dermatitis; children; GUIDELINES; ECZEMA;

D O I：

10.1111/pai.13390

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Atopic dermatitis (AD) is a chronic remitting-relapsing inflammatory skin disorder. Due to the multifactorial pathogenesis, there are numerous therapeutic management approaches, mainly based on symptomatic treatments. In recent years, allergen immunotherapy (AIT) has been progressively advanced as targeted disease-modifying treatment of allergic disease. The most recent guideline from the American Academy of Dermatology concludes that data available do not support its use in AD. The Joint Task Force and The European Academy of Dermatology suggest that clinicians can consider AIT treatment in selected patients characterized by aeroallergen sensitization, prevalently HDM, severe AD, and clinical exacerbation after exposure to the causative allergen. Nevertheless, its role in AD is still under debate, especially in children.

引用

页码：46 / 48

页数：3

共 50 条

[1] Advancements in Allergen Immunotherapy for the Treatment of Atopic Dermatitis
Guo, Bei-Cyuan
Wu, Kang-Hsi
Chen, Chun-Yu
Lin, Wen-Ya
Chang, Yu-Jun
Lin, Mao-Jen
Wu, Han-Ping
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
[2] Allergen immunotherapy in atopic dermatitis
Ridolo, Erminia
Martignago, Irene
Riario-Sforza, Gian Galeazzo
Incorvaia, Cristoforo
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (01) : 61 - 68
[3] Allergen immunotherapy in atopic dermatitis
Bogacz-Piaseczynka, Agnieszka
Bozek, Andrzej
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2024, 11 (03) : 257 - 263
[4] Allergen Immunotherapy and Atopic Dermatitis: the Good, the Bad, and the Unknown
Rizk, Patrick
Rodenas, Mario
De Benedetto, Anna
CURRENT ALLERGY AND ASTHMA REPORTS, 2019, 19 (12)
[5] Allergen immunotherapy for atopic dermatitis
Traidi, Stephan
Werfel, Thomas
HAUTARZT, 2021, 72 (12): : 1103 - 1112
[6] Allergen Immunotherapy for Atopic Dermatitis: Is There Room for Debate?
Cox, Linda
Calderon, Moises A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (03) : 435 - 444
[7] Allergen specific immunotherapy for atopic dermatitis
Novak, Natalija
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 7 (06) : 542 - 546
[8] The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites
Bogacz-Piaseczynska, Agnieszka
Bozek, Andrzej
MEDICINA-LITHUANIA, 2023, 59 (01):
[9] Allergen-specific immunotherapy in atopic dermatitis
Jutel, Marek
Solarewicz-Madejek, Katarzyna
Wegrzyn, Agnieszka
POSTEPY DERMATOLOGII I ALERGOLOGII, 2011, 28 (05): : 389 - 395
[10] Allergen immunotherapy and dupilumab in atopic dermatitis: Clinical efficacy and disparities in immunological indicators
Liu, Jin
Yang, Lin
Xu, Qingxiu
Jiang, Qing
Huang, Nan
Li, Wenjing
Yang, Yaqi
Ma, Dongxia
Li, Le
Fu, Yangxue
Chen, Hao
Zhu, Rongfei
WORLD ALLERGY ORGANIZATION JOURNAL, 2025, 18 (03):

← 1 2 3 4 5 →